Eli Lilly’s BAQSIMI nasal powder set to treat severe hypoglycemia

North America |  News | 0 Comment | 25 Jul, 2019

The U.S. Food and Drug Administration (FDA) has approved BAQSIMI™ (glucagon) nasal powder 3 mg for the treatment of severe hypoglycemia in people with diabetes ages four years and abo...Read more

Health catalyst announces pricing of IPO

North America |  News | 0 Comment | 25 Jul, 2019

Health Catalyst, a leading provider of data and analytics technology and services to healthcare organizations has announced the pricing of its initial public offering of 7,000,000 shares of...Read more

Pall Corporation Chosen as Single-Source Supplier by Servier

North America |  News | 0 Comment | 20 Jul, 2019

PORT WASHINGTON, N.Y (US). – July 20, 2019 – Pall Corporation, a global leader in filtration, separation and purification, has been chosen by Servier, an independent ...Read more

Oncoceutics Announces Support for All Those Affected by Gliomas on Glioblastoma Awareness Day

North America |  News | 0 Comment | 20 Jul, 2019

Philadelphia, PA (July 17, 2019) – Oncoceutics, Inc. issues this announcement on Glioblastoma Awareness Day to reiterate its support for all those suffering from, or broadly affecte...Read more

New Vaccine in the Treatment of Rheumatoid Arthritis

North America |  News | 0 Comment | 09 Jul, 2019

CEL-SCI Corporation (NYSE American: CVM) announced that one of its key collaborators from Rush University Medical center, Dr. Adrienn Markovitz an Assistant professor in the depar...Read more

Platelet BioGenesis appoints Sam Rasty as President & CEO

North America |  News | 0 Comment | 02 Jul, 2019

Platelet BioGenesis, the leader in stem cell-derived, on-demand human platelets (PLTs+) and platelet-based therapeutics has announced the hiring of Sam Rasty, Ph.D., as President and C...Read more

Synthetic Biologics regains compliance with NYSE American continued listing standards

North America |  News | 0 Comment | 02 Jul, 2019

Synthetic Biologics, a late-stage clinical company developing therapeutics that preserve the microbiome to protect and restore the health of patients, announced today receipt, on ...Read more

EWIB Partners with BIO to Promote Gender Diversity on Corporate Boards

North America |  News | 0 Comment | 27 Jun, 2019

Executive Women in Bio (EWIB), a committee comprised of senior leaders in the life sciences and biopharma operating within the national non-profit organization, Women In Bio (WIB), is pleas...Read more

Syneos Health Consulting releases 11th annual survey of Biopharmaceutical dealmakers

North America |  News | 0 Comment | 06 Jun, 2019

The 11th annual Dealmakers’ Intentions Study from Syneos Health Consulting, an industry-leading biopharmaceutical management consulting firm, indicates that there will be an accelerat...Read more

Discovery Labs to develop a $500M co-working community

North America |  News | 0 Comment | 06 Jun, 2019

The Discovery Labs, a platform company formed by MLP Ventures, announced at BIO 2019 (Booth 4134) it is redeveloping GlaxoSmithKline's one million square foot Upper Merion West Campus and t...Read more

InterVenn BioSciences Enrolls First Patients in VOCAL Trial

North America |  News | 0 Comment | 04 Jun, 2019

CHICAGO & REDWOOD CITY, Calif. InterVenn BioSciences, a life sciences and technology company developing an AI-driven mass spectrometry platform, announced today the first patients have...Read more

THBI to Philadelphia for 2019 Annual BIO Convention

North America |  News | 0 Comment | 04 Jun, 2019

AUSTIN, TX – June 3, 2019 – The Texas Healthcare and Bioscience Institute (THBI) is headed to Philadelphia this week to showcase the state’s thriving biotechnology and lif...Read more